ZA200108082B - Pharmaceutical compositions comprising dipeptidy peptidase IV inhibitors for the promotion of growth. - Google Patents
Pharmaceutical compositions comprising dipeptidy peptidase IV inhibitors for the promotion of growth.Info
- Publication number
- ZA200108082B ZA200108082B ZA200108082A ZA200108082A ZA200108082B ZA 200108082 B ZA200108082 B ZA 200108082B ZA 200108082 A ZA200108082 A ZA 200108082A ZA 200108082 A ZA200108082 A ZA 200108082A ZA 200108082 B ZA200108082 B ZA 200108082B
- Authority
- ZA
- South Africa
- Prior art keywords
- promotion
- inhibitors
- growth
- pharmaceutical compositions
- dipeptidy peptidase
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/02—Drugs for disorders of the endocrine system of the hypothalamic hormones, e.g. TRH, GnRH, CRH, GRH, somatostatin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/06—Drugs for disorders of the endocrine system of the anterior pituitary hormones, e.g. TSH, ACTH, FSH, LH, PRL, GH
Landscapes
- Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Epidemiology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Endocrinology (AREA)
- Diabetes (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Peptides Or Proteins (AREA)
- Pyrrole Compounds (AREA)
- Thiazole And Isothizaole Compounds (AREA)
- Medicinal Preparation (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GBGB9906715.9A GB9906715D0 (en) | 1999-03-23 | 1999-03-23 | Compositions for promoting growth |
Publications (1)
Publication Number | Publication Date |
---|---|
ZA200108082B true ZA200108082B (en) | 2002-12-24 |
Family
ID=10850230
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
ZA200108082A ZA200108082B (en) | 1999-03-23 | 2001-10-02 | Pharmaceutical compositions comprising dipeptidy peptidase IV inhibitors for the promotion of growth. |
Country Status (26)
Country | Link |
---|---|
US (1) | US6521644B1 (xx) |
EP (1) | EP1171121B1 (xx) |
JP (1) | JP2002539244A (xx) |
KR (1) | KR100704348B1 (xx) |
CN (1) | CN1359293A (xx) |
AR (1) | AR023130A1 (xx) |
AT (1) | ATE297728T1 (xx) |
AU (1) | AU772421B2 (xx) |
CA (1) | CA2366926A1 (xx) |
CZ (1) | CZ20013411A3 (xx) |
DE (1) | DE60020825T2 (xx) |
GB (1) | GB9906715D0 (xx) |
HK (1) | HK1048589A1 (xx) |
HU (1) | HUP0200391A3 (xx) |
IL (2) | IL145568A0 (xx) |
MX (1) | MXPA01009610A (xx) |
MY (1) | MY124214A (xx) |
NO (1) | NO20014608L (xx) |
NZ (1) | NZ514450A (xx) |
PL (1) | PL195529B1 (xx) |
RU (1) | RU2242228C2 (xx) |
TR (1) | TR200102648T2 (xx) |
TW (1) | TWI239246B (xx) |
UA (1) | UA73115C2 (xx) |
WO (1) | WO2000056297A2 (xx) |
ZA (1) | ZA200108082B (xx) |
Families Citing this family (53)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20040152745A1 (en) * | 1999-11-12 | 2004-08-05 | Guilford Pharmaceuticals, Inc. | Dipeptidyl peptidase IV inhibitors and methods of making and using dipeptidyl peptidase IV inhibitors |
GB9928330D0 (en) | 1999-11-30 | 2000-01-26 | Ferring Bv | Novel antidiabetic agents |
US6395767B2 (en) | 2000-03-10 | 2002-05-28 | Bristol-Myers Squibb Company | Cyclopropyl-fused pyrrolidine-based inhibitors of dipeptidyl peptidase IV and method |
DE60223920T2 (de) * | 2001-06-27 | 2008-11-13 | Smithkline Beecham Corp. | Pyrrolidine als dipeptidyl-peptidase-inhibitoren |
UA74912C2 (en) | 2001-07-06 | 2006-02-15 | Merck & Co Inc | Beta-aminotetrahydroimidazo-(1,2-a)-pyrazines and tetratriazolo-(4,3-a)-pyrazines as inhibitors of dipeptylpeptidase for the treatment or prevention of diabetes |
JP2006510630A (ja) * | 2002-12-04 | 2006-03-30 | メルク エンド カムパニー インコーポレーテッド | 糖尿病を治療又は予防するためのジペプチジルペプチダーゼ阻害剤としてのフェニルアラニン誘導体 |
US7550590B2 (en) * | 2003-03-25 | 2009-06-23 | Takeda Pharmaceutical Company Limited | Dipeptidyl peptidase inhibitors |
EP1625122A1 (en) | 2003-05-14 | 2006-02-15 | Takeda San Diego, Inc. | Dipeptidyl peptidase inhibitors |
US7678909B1 (en) | 2003-08-13 | 2010-03-16 | Takeda Pharmaceutical Company Limited | Dipeptidyl peptidase inhibitors |
US7169926B1 (en) | 2003-08-13 | 2007-01-30 | Takeda Pharmaceutical Company Limited | Dipeptidyl peptidase inhibitors |
BRPI0413452A (pt) * | 2003-08-13 | 2006-10-17 | Takeda Pharmaceutical | composto, composição farmacêutica, kit, artigo de fabricação, e, métodos de inibir dpp-iv, terapêutico e de tratar um estado de doença, cáncer, distúrbios autoimunes, uma condição einfecção por hiv |
US20050065144A1 (en) * | 2003-09-08 | 2005-03-24 | Syrrx, Inc. | Dipeptidyl peptidase inhibitors |
JP2007505121A (ja) * | 2003-09-08 | 2007-03-08 | 武田薬品工業株式会社 | ジペプチジルぺプチダーゼ阻害剤 |
US7732446B1 (en) | 2004-03-11 | 2010-06-08 | Takeda Pharmaceutical Company Limited | Dipeptidyl peptidase inhibitors |
AU2004318013B8 (en) * | 2004-03-15 | 2011-10-06 | Takeda Pharmaceutical Company Limited | Dipeptidyl peptidase inhibitors |
US7687638B2 (en) * | 2004-06-04 | 2010-03-30 | Takeda San Diego, Inc. | Dipeptidyl peptidase inhibitors |
WO2006019965A2 (en) | 2004-07-16 | 2006-02-23 | Takeda San Diego, Inc. | Dipeptidyl peptidase inhibitors |
EP2805953B1 (en) * | 2004-12-21 | 2016-03-09 | Takeda Pharmaceutical Company Limited | Dipeptidyl peptidase inhibitors |
DOP2006000008A (es) | 2005-01-10 | 2006-08-31 | Arena Pharm Inc | Terapia combinada para el tratamiento de la diabetes y afecciones relacionadas y para el tratamiento de afecciones que mejoran mediante un incremento de la concentración sanguínea de glp-1 |
ZA200708179B (en) * | 2005-04-22 | 2009-12-30 | Alantos Pharmaceuticals Holding Inc | Dipeptidyl peptidase-IV inhibitors |
WO2007033350A1 (en) | 2005-09-14 | 2007-03-22 | Takeda Pharmaceutical Company Limited | Dipeptidyl peptidase inhibitors for treating diabetes |
CA2622608C (en) * | 2005-09-14 | 2014-08-19 | Takeda Pharmaceutical Company Limited | Dipeptidyl peptidase inhibitors for treating diabetes |
US20070060529A1 (en) * | 2005-09-14 | 2007-03-15 | Christopher Ronald J | Administration of dipeptidyl peptidase inhibitors |
EP1924567B1 (en) * | 2005-09-16 | 2012-08-22 | Takeda Pharmaceutical Company Limited | Process for the preparation of pyrimidinedione derivatives |
TW200745080A (en) * | 2005-09-16 | 2007-12-16 | Takeda Pharmaceuticals Co | Polymorphs of tartrate salt of 2-[2-(3-(R)-amino-piperidin-1-yl)-5-fluoro-6-oxo-6H-pyrimidin-1-ylmethyl]-benzonitrile and methods of use therefor |
TW200745079A (en) * | 2005-09-16 | 2007-12-16 | Takeda Pharmaceuticals Co | Polymorphs of benzoate salt of 2-[[6-[(3R)-3-amino-1-piperidinyl]-3,4-dihydro-3-methyl-2,4-dioxo-1(2H)-pyrimidinyl]methyl]-benzonitrile and methods of use therefor |
JP2009531456A (ja) * | 2006-03-28 | 2009-09-03 | 武田薬品工業株式会社 | (r)−3−アミノピペリジン二塩酸塩の調製 |
WO2007112347A1 (en) | 2006-03-28 | 2007-10-04 | Takeda Pharmaceutical Company Limited | Dipeptidyl peptidase inhibitors |
PE20071221A1 (es) | 2006-04-11 | 2007-12-14 | Arena Pharm Inc | Agonistas del receptor gpr119 en metodos para aumentar la masa osea y para tratar la osteoporosis y otras afecciones caracterizadas por masa osea baja, y la terapia combinada relacionada a estos agonistas |
US8324383B2 (en) | 2006-09-13 | 2012-12-04 | Takeda Pharmaceutical Company Limited | Methods of making polymorphs of benzoate salt of 2-[[6-[(3R)-3-amino-1-piperidinyl]-3,4-dihydro-3-methyl-2,4-dioxo-1(2H)-pyrimidinyl]methyl]-benzonitrile |
AR062760A1 (es) * | 2006-09-13 | 2008-12-03 | Takeda Pharmaceutical | Administracion de inhibidores de dipeptidilpetidasa |
TW200838536A (en) * | 2006-11-29 | 2008-10-01 | Takeda Pharmaceutical | Polymorphs of succinate salt of 2-[6-(3-amino-piperidin-1-yl)-3-methyl-2,4-dioxo-3,4-dihydro-2H-pyrimidin-1-ylmethy]-4-fluor-benzonitrile and methods of use therefor |
US8093236B2 (en) | 2007-03-13 | 2012-01-10 | Takeda Pharmaceuticals Company Limited | Weekly administration of dipeptidyl peptidase inhibitors |
EP2146210A1 (en) | 2008-04-07 | 2010-01-20 | Arena Pharmaceuticals, Inc. | Methods of using A G protein-coupled receptor to identify peptide YY (PYY) secretagogues and compounds useful in the treatment of conditions modulated by PYY |
JO2870B1 (en) | 2008-11-13 | 2015-03-15 | ميرك شارب اند دوهم كورب | Amino Tetra Hydro Pirans as Inhibitors of Peptide Dipeptide IV for the Treatment or Prevention of Diabetes |
AR077642A1 (es) | 2009-07-09 | 2011-09-14 | Arena Pharm Inc | Moduladores del metabolismo y el tratamiento de trastornos relacionados con el mismo |
JP5734981B2 (ja) | 2009-09-02 | 2015-06-17 | メルク・シャープ・エンド・ドーム・コーポレイション | 糖尿病の治療又は予防のためのジペプチジルペプチダーゼiv阻害剤としてのアミノテトラヒドロピラン |
US8648073B2 (en) | 2009-12-30 | 2014-02-11 | Fochon Pharma, Inc. | Certain dipeptidyl peptidase inhibitors |
EP2538783B1 (en) | 2010-02-22 | 2016-06-01 | Merck Sharp & Dohme Corp. | Substituted aminotetrahydrothiopyrans and derivatives thereof as dipeptidyl peptidase-iv inhibitors for the treatment of diabetes |
BR112012025592A2 (pt) | 2010-04-06 | 2019-09-24 | Arena Pharm Inc | moduladores do receptor de gpr119 e o tratamento de distúrbios relacionados com os mesmos |
WO2011146358A1 (en) | 2010-05-21 | 2011-11-24 | Merck Sharp & Dohme Corp. | Substituted seven-membered heterocyclic compounds as dipeptidyl peptidase-iv inhibitors for the treatment of diabetes |
AU2011305525B2 (en) | 2010-09-22 | 2016-08-18 | Arena Pharmaceuticals, Inc. | Modulators of the GPR119 receptor and the treatment of disorders related thereto |
WO2012135570A1 (en) | 2011-04-01 | 2012-10-04 | Arena Pharmaceuticals, Inc. | Modulators of the gpr119 receptor and the treatment of disorders related thereto |
US20140066369A1 (en) | 2011-04-19 | 2014-03-06 | Arena Pharmaceuticals, Inc. | Modulators Of The GPR119 Receptor And The Treatment Of Disorders Related Thereto |
WO2012145603A1 (en) | 2011-04-22 | 2012-10-26 | Arena Pharmaceuticals, Inc. | Modulators of the gpr119 receptor and the treatment of disorders related thereto |
US20140051714A1 (en) | 2011-04-22 | 2014-02-20 | Arena Pharmaceuticals, Inc. | Modulators Of The GPR119 Receptor And The Treatment Of Disorders Related Thereto |
WO2012170702A1 (en) | 2011-06-08 | 2012-12-13 | Arena Pharmaceuticals, Inc. | Modulators of the gpr119 receptor and the treatment of disorders related thereto |
WO2013055910A1 (en) | 2011-10-12 | 2013-04-18 | Arena Pharmaceuticals, Inc. | Modulators of the gpr119 receptor and the treatment of disorders related thereto |
US9073930B2 (en) | 2012-02-17 | 2015-07-07 | Merck Sharp & Dohme | Dipeptidyl peptidase-IV inhibitors for the treatment or prevention of diabetes |
WO2014018350A1 (en) | 2012-07-23 | 2014-01-30 | Merck Sharp & Dohme Corp. | Treating diabetes with dipeptidyl peptidase-iv inhibitors |
WO2014074668A1 (en) | 2012-11-08 | 2014-05-15 | Arena Pharmaceuticals, Inc. | Modulators of gpr119 and the treatment of disorders related thereto |
KR20180006881A (ko) | 2015-03-09 | 2018-01-19 | 인테크린 테라퓨틱스, 아이엔씨. | 비알코올성 지방간 질환 및/또는 지방이영양증의 치료 방법 |
JP2020515639A (ja) | 2017-04-03 | 2020-05-28 | コヒラス・バイオサイエンシズ・インコーポレイテッド | 進行性核上性麻痺の処置のためのPPARγアゴニスト |
Family Cites Families (10)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
ES2099158T3 (es) | 1990-04-14 | 1997-05-16 | New England Medical Center Inc | Tratamiento del rechazo de trasplantes o de enfermedades autoinmunitarias y complejo de la formula general x-pro-y-boropro asociada al mismo. |
HUT63857A (en) * | 1990-11-14 | 1993-10-28 | Upjohn Co | Process for producing grf-analogs |
JPH0543453A (ja) * | 1991-08-20 | 1993-02-23 | Sumitomo Pharmaceut Co Ltd | 創傷治癒促進用局所用徐放性製剤 |
HUT67319A (en) * | 1991-08-30 | 1995-03-28 | Life Medical Sciences Inc | Compositions for treating wounds |
CA2121369C (en) * | 1991-10-22 | 2003-04-29 | William W. Bachovchin | Inhibitors of dipeptidyl-aminopeptidase type iv |
IL111785A0 (en) * | 1993-12-03 | 1995-01-24 | Ferring Bv | Dp-iv inhibitors and pharmaceutical compositions containing them |
JPH09295946A (ja) * | 1995-05-16 | 1997-11-18 | Mitsui Pharmaceut Inc | 医薬組成物 |
JPH09308259A (ja) * | 1996-05-17 | 1997-11-28 | Toshiba Lighting & Technol Corp | 電源装置、放電ランプ点灯装置及び照明装置 |
TW492957B (en) | 1996-11-07 | 2002-07-01 | Novartis Ag | N-substituted 2-cyanopyrrolidnes |
US5952301A (en) | 1996-12-10 | 1999-09-14 | 1149336 Ontario Inc. | Compositions and methods for enhancing intestinal function |
-
1999
- 1999-03-23 GB GBGB9906715.9A patent/GB9906715D0/en not_active Ceased
-
2000
- 2000-03-21 AT AT00911195T patent/ATE297728T1/de not_active IP Right Cessation
- 2000-03-21 IL IL14556800A patent/IL145568A0/xx active IP Right Grant
- 2000-03-21 EP EP00911195A patent/EP1171121B1/en not_active Expired - Lifetime
- 2000-03-21 US US09/937,031 patent/US6521644B1/en not_active Expired - Fee Related
- 2000-03-21 WO PCT/IB2000/000393 patent/WO2000056297A2/en not_active Application Discontinuation
- 2000-03-21 AU AU33186/00A patent/AU772421B2/en not_active Ceased
- 2000-03-21 CA CA002366926A patent/CA2366926A1/en not_active Abandoned
- 2000-03-21 NZ NZ514450A patent/NZ514450A/xx unknown
- 2000-03-21 CN CN00805326A patent/CN1359293A/zh active Pending
- 2000-03-21 RU RU2001128504/15A patent/RU2242228C2/ru not_active IP Right Cessation
- 2000-03-21 TR TR2001/02648T patent/TR200102648T2/xx unknown
- 2000-03-21 JP JP2000606202A patent/JP2002539244A/ja active Pending
- 2000-03-21 KR KR1020017012145A patent/KR100704348B1/ko not_active IP Right Cessation
- 2000-03-21 HU HU0200391A patent/HUP0200391A3/hu unknown
- 2000-03-21 CZ CZ20013411A patent/CZ20013411A3/cs unknown
- 2000-03-21 MX MXPA01009610A patent/MXPA01009610A/es active IP Right Grant
- 2000-03-21 PL PL00350796A patent/PL195529B1/pl unknown
- 2000-03-21 DE DE60020825T patent/DE60020825T2/de not_active Expired - Fee Related
- 2000-03-21 MY MYPI20001117A patent/MY124214A/en unknown
- 2000-03-21 UA UA2001096487A patent/UA73115C2/uk unknown
- 2000-03-22 AR ARP000101281A patent/AR023130A1/es unknown
- 2000-03-23 TW TW089105321A patent/TWI239246B/zh not_active IP Right Cessation
-
2001
- 2001-09-21 NO NO20014608A patent/NO20014608L/no not_active Application Discontinuation
- 2001-09-23 IL IL145568A patent/IL145568A/en unknown
- 2001-10-02 ZA ZA200108082A patent/ZA200108082B/xx unknown
-
2002
- 2002-11-29 HK HK02108644.1A patent/HK1048589A1/zh unknown
Also Published As
Publication number | Publication date |
---|---|
US6521644B1 (en) | 2003-02-18 |
ATE297728T1 (de) | 2005-07-15 |
RU2242228C2 (ru) | 2004-12-20 |
CA2366926A1 (en) | 2000-09-28 |
WO2000056297A3 (en) | 2001-01-25 |
NZ514450A (en) | 2002-11-26 |
IL145568A (en) | 2007-09-20 |
UA73115C2 (en) | 2005-06-15 |
IL145568A0 (en) | 2002-06-30 |
EP1171121A2 (en) | 2002-01-16 |
KR100704348B1 (ko) | 2007-04-05 |
WO2000056297A2 (en) | 2000-09-28 |
CZ20013411A3 (cs) | 2002-04-17 |
TWI239246B (en) | 2005-09-11 |
HUP0200391A3 (en) | 2002-11-28 |
AU3318600A (en) | 2000-10-09 |
TR200102648T2 (tr) | 2001-12-21 |
NO20014608D0 (no) | 2001-09-21 |
HUP0200391A2 (en) | 2002-06-29 |
MXPA01009610A (es) | 2002-07-02 |
CN1359293A (zh) | 2002-07-17 |
JP2002539244A (ja) | 2002-11-19 |
AR023130A1 (es) | 2002-09-04 |
PL350796A1 (en) | 2003-02-10 |
EP1171121B1 (en) | 2005-06-15 |
NO20014608L (no) | 2001-10-31 |
GB9906715D0 (en) | 1999-05-19 |
KR20010108389A (ko) | 2001-12-07 |
DE60020825D1 (de) | 2005-07-21 |
DE60020825T2 (de) | 2006-05-04 |
PL195529B1 (pl) | 2007-09-28 |
MY124214A (en) | 2006-06-30 |
AU772421B2 (en) | 2004-04-29 |
HK1048589A1 (zh) | 2003-04-11 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
ZA200108082B (en) | Pharmaceutical compositions comprising dipeptidy peptidase IV inhibitors for the promotion of growth. | |
HUP0200347A2 (en) | N-cyanomethylamides as protease inhibitors, pharmaceutical compositions containing them and their use | |
HUP0004120A3 (en) | Use of cgmp-pde5 inhibitors for the preparation of pharmaceutical compositions treating neuropathy | |
IL150225A0 (en) | Lipopeptides, pharmaceutical compositions containing the same and methods for the production thereof | |
HK1045650A1 (en) | Pharmaceutical composition. | |
ZA200109890B (en) | Metalloprotease inhibitors. | |
HUP0102250A3 (en) | Compounds of unstable dipeptidyl peptidase iv inhibitors, pharmaceutical compositions comprising thereof and their use | |
HK1041693A1 (en) | Dimeric compounds and as inhibitors of neuraminidase. | |
HUP0105077A3 (en) | Serine protease inhibitors and pharmaceutical compositions containing them | |
ZA200106104B (en) | Pharmaceutical composition containing proton pump inhibitors. | |
HK1048271A1 (en) | Pharmaceutical composition for inhibiting retinoidskin damage. | |
ZA200203486B (en) | Novel pharmaceutical compositions. | |
HUP0202938A3 (en) | N-aryl-2-sulfonamidobenzamides as phosphate transport inhibitors and pharmaceutical compositions containing them | |
HUP0001632A3 (en) | Pharmaceutical compositions comprising selective phosphodiestherase inhibitors | |
AU3556400A (en) | Pharmaceutical compositions | |
ZA200000857B (en) | Pharmaceutical composition. | |
AU2001238346A1 (en) | Modification of biopolymers for improved drug delivery | |
HUP0200608A3 (en) | Heterocyclic compounds, intermediates thereof and elastase inhibitors and pharmaceutical compositions containing them | |
AU2001275810A1 (en) | The pharmaceutical composition comprising arginine deiminase for inhibiting angiogenesis | |
PL358538A1 (en) | New pharmaceutical combinations for nos inhibitors | |
ZA200203077B (en) | Ciclesonide contained pharmaceutical composition for application to mucosa. | |
GB9907571D0 (en) | Compounds | |
ZA200110053B (en) | Factor via inhibitors. | |
GB9911017D0 (en) | Pharmaceutical compositions | |
HUP0200928A3 (en) | Pyrido-thieno-diazepines, method for the production thereof and pharmaceutical compositions containing said pyrido-thieno-diazepines |